Issue 1 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

28

No.

1

January 28, 2005Jan 28, 2005

Free

DOWNLOAD THE PDF

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

New Regimens May Benefit Multiple Myeloma Patients

Two New Modalities Promising For Relapsed/Refractory NHL

Amgen’s Kepivance Approved For Severe Oral Mucositis

Clolar Approved for Pediatric Refractory/Relapsed ALL

Blacks Half As Likely To Get Surgery For Esophageal Cancer

NCI-Approved Clinical Trials Listed For January

Recent Issues

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026

Volume 52 | Issue 10 - March 13, 2026